SNDL Inc. - Common Shares (SNDL)
1.7400
-0.0700 (-3.87%)
Sndl Inc is a publicly traded company focused on the cannabis industry, primarily involved in the cultivation, production, and distribution of cannabis products
The company operates various facilities where it grows a range of cannabis strains and processes these into finished goods such as dried flower, oils, and edibles. In addition to its production activities, Sndl Inc also engages in retail operations, selling its products through dispensaries and online channels. With a commitment to quality and compliance, the company aims to provide consumers with a diverse selection of cannabis products while navigating the evolving regulations in the cannabis market.
Previous Close | 1.810 |
---|---|
Open | 1.780 |
Bid | 1.740 |
Ask | 1.760 |
Day's Range | 1.740 - 1.830 |
52 Week Range | 1.300 - 2.930 |
Volume | 1,710,053 |
Market Cap | 409.24M |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,916,499 |
News & Press Releases
420 with CNW — Pesticides, Bacteria Found in Marijuana Available in Dutch Coffee Shops
An investigation into marijuana sold in Dutch semi-legal coffee stores has uncovered a range of contaminants, including pesticides, lead, and harmful bacteria. The Netherlands Institute of Mental Health and Addiction study was designed to find a “baseline” for contamination levels typically found in cannabis products.
Via CannabisNewsWire · January 30, 2025
420 with CNW — Observers Say Budgetary Pressures Could Boost Efforts to Legalize Marijuana in Iowa
A significant portion of adults in the U.S. remains in favor of cannabis legalization . However, despite this momentum, three out of four recreational legalization initiatives—proposed in Florida, South Dakota, and North Dakota—failed during the November elections.
Via CannabisNewsWire · January 17, 2025
420 with CNW — Latest Scientific Review Finds CBD Has Potential to Treat Depression, with Minimal Side Effects
A recent scientific review highlights increasing evidence that cannabidiol (CBD), a compound found in cannabis, has antidepressant effects on both animals and humans, with minimal side effects. The review also suggests that CBD may contribute to reducing inflammation and encouraging the growth of new brain cells.
Via CannabisNewsWire · January 7, 2025
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'benzinga.com
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.
Via Benzinga · January 3, 2025
420 with CNW — New York Marijuana Firms Call for Tax Reforms as They Struggle to Survive
New York marijuana cultivators and processors are pushing Governor Kathy Hochul to approve a measure that would simplify how they handle tax filings, switching the system to an annual basis.
Via CannabisNewsWire · December 23, 2024
420 with CNW — Study Suggests Marijuana Use Could Trigger Epigenetic Changes
A recent study published in the journal Molecular Psychiatry has explored how marijuana use might influence the epigenome in the human body . The epigenome, often described as a system of switches, regulates how genes are activated or deactivated, shaping bodily functions.
Via CannabisNewsWire · December 11, 2024
420 with CNW — FDA OKs Study Exploring Marijuana Use for Treating PTSD in Veterans
This week, the U.S. Food and Drug Administration (FDA) granted long-awaited approval for a clinical trial exploring whether cannabis can help manage veterans’ post-traumatic stress disorder (PTSD).
Via CannabisNewsWire · December 4, 2024
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nomineebenzinga.com
The AdvisorShares Pure US Cannabis ETF (NYSEMSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.
Via Benzinga · November 21, 2024
420 with CNW — Scientists Doubt Findings of Study Indicating Federally-Sourced Research Marijuana Doesn’t Differ from State-Legal Products
A recent study conducted by Mahmoud ElSohly, one of the few individuals authorized by the federal government to grow cannabis for research, has found that marijuana available in the U.S. market has a consistent cannabinoid profile, primarily shaped by genetics rather than regional factors.
Via CannabisNewsWire · November 20, 2024
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?benzinga.com
After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip?
Via Benzinga · November 7, 2024
US Jurisdictions that Voted on Marijuana Legalization Could Generate $3 Billion Upon Launch
Different jurisdictions across America voted on initiatives to legalize marijuana on Election Day. Voters in the states of Florida, North Dakota and Nebraska voted on measures to legalize adult-use and medical marijuana this month.
Via CannabisNewsWire · November 7, 2024
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Closebenzinga.com
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.
Via Benzinga · November 6, 2024
SNDL (SNDL) Q3 2024 Earnings Call Transcriptfool.com
SNDL earnings call for the period ending September 30, 2024.
Via The Motley Fool · November 5, 2024
Cannabis Stocks React On Election Day, SNDL Surges While Trulieve Raised The Stakesbenzinga.com
On Election Day, cannabis stocks had mixed results. SNDL soared with strong financials, while Trulieve's stock dropped while waiting Florida.
Via Benzinga · November 5, 2024
SNDL's Q3 Revenue Slides Year-Over-Year Due To Liquor Market Softening, Cannabis Operations Going Strongbenzinga.com
Via Benzinga · November 5, 2024
Cannabis Stocks Sink Amid Broader Market Decline And Election Jittersbenzinga.com
Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.
Via Benzinga · October 31, 2024
420 with CNW — Delaware Cannabis Business Sites Dwindle as Local Bans Take Effect
Last year, when Delaware legalized cannabis, legislators approved the opening of 30 retail cannabis stores across the state. However, despite licenses being expected this year and stores potentially launching by 2025, available locations for shoppers to purchase cannabis legally are declining.
Via CannabisNewsWire · October 30, 2024
M&A Frenzy And Deflation Post-Election: Which Companies Are Ready To Win Big In Florida's Cannabis Marketbenzinga.com
November's election could bring significant growth opportunities—or intensified competition for cannabis companies in the Florida market.
Via Benzinga · October 26, 2024
Cannabis Stocks Rally: Canopy, Aurora, SNDL, OrganiGram And Others See Gainsbenzinga.com
Cannabis stocks rally as Canopy Growth, Aurora Cannabis, SNDL, and OrganiGram show positive momentum. We look at resistance levels...
Via Benzinga · October 25, 2024